- Home
- ANTX vs GROW Comparison
ANTX vs GROW Comparison
Compare ANTX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- GROW
- Stock Information
- Founded
- ANTX 2017
- GROW 1968
- Country
- ANTX United States
- GROW United States
- Employees
- ANTX N/A
- GROW 26
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- ANTX Health Care
- GROW Finance
- Exchange
- ANTX Nasdaq
- GROW Nasdaq
- Market Cap
- ANTX 40.0M
- GROW 33.1M
- IPO Year
- ANTX 2022
- GROW N/A
- Fundamental
- Price
- ANTX $1.44
- GROW $2.45
- Analyst Decision
- ANTX Hold
- GROW
- Analyst Count
- ANTX 5
- GROW 0
- Target Price
- ANTX $3.50
- GROW N/A
- AVG Volume (30 Days)
- ANTX 298.6K
- GROW 22.4K
- Earning Date
- ANTX 11-13-2024
- GROW 02-06-2025
- Dividend Yield
- ANTX N/A
- GROW 3.63%
- EPS Growth
- ANTX N/A
- GROW N/A
- EPS
- ANTX N/A
- GROW 0.12
- Revenue
- ANTX N/A
- GROW $10,008,000.00
- Revenue This Year
- ANTX N/A
- GROW N/A
- Revenue Next Year
- ANTX N/A
- GROW N/A
- P/E Ratio
- ANTX N/A
- GROW $20.22
- Revenue Growth
- ANTX N/A
- GROW N/A
- 52 Week Low
- ANTX $0.87
- GROW $2.38
- 52 Week High
- ANTX $22.22
- GROW $2.95
- Technical
- Relative Strength Index (RSI)
- ANTX 56.85
- GROW 53.57
- Support Level
- ANTX $1.23
- GROW $2.41
- Resistance Level
- ANTX $1.43
- GROW $2.45
- Average True Range (ATR)
- ANTX 0.09
- GROW 0.04
- MACD
- ANTX -0.01
- GROW 0.00
- Stochastic Oscillator
- ANTX 58.33
- GROW 62.50
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.